Latest news
ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of XBB 1.5 COVID-19 vaccines.
ATAGI update additional 2023 COVID-19 vaccination dose
The Australian Technical Advisory Group on Immunisation (ATAGI) recently updated their advice for the COVID-19 booster dose.
ATAGI Update on the COVID-19 Vaccination Program
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding an additional COVID-19 dose for highest risk people in 2023. These recommendations are in addition the previous ATAGI COVID-19 vaccine booster advice published in February 2023.
Protecting Older Australians – COVID-19 Update 5 July 2023
Read the Protecting Older Australians COVID-19 update newsletter from 5 July 2023.
Protecting Older Australians – COVID-19 Update 21 June 2023
Read the Protecting Older Australians COVID-19 update newsletter from 21 June 2023.
Protecting Older Australians – COVID-19 Update 2 June 2023
Read the Protecting Older Australians COVID-19 update newsletter from 2 June 2023.
ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older
ATAGI has made recommendations on the use of bivalent COVID-19 vaccines as a primary course.
Protecting Older Australians – COVID-19 update 22 May 2023
Read the Protecting Older Australians COVID-19 update newsletter from 22 May 2023.
Protecting Older Australians – COVID-19 update 8 May 2023
In this issue, read about managing COVID-19, COVID-19 vaccination booster doses, influenza vaccinations, accessing COVID-19 PCR testing through Medicare, IPC Lead Nurse training grants, PPE winter deployment, and the ACCPA Winter preparedness webinar.
Protecting Older Australians – COVID-19 update 4 April 2023
In this issue: Letter to aged care providers on COVID-19 preparedness, Infection Control and Prevention (IPC) overview, Provider IPC responsibility, The commission's IPC oversight and IPC training grants available.
Top up your COVID-19 protection
The Australian Government has launched a new advertising campaign to encourage adults to get a COVID-19 booster if it has been 6 months or more since their last COVID-19 vaccination or infection.
Release of the Australian Government's response to the Review of COVID-19 Vaccine and Treatment Purchasing and Procurement
The Australian Government has responded to the Halton review into COVID-19 vaccine and treatment procurement.
ATAGI recommendations on use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.
ATAGI 2023 booster advice
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 boosters in 2023. These recommendations replace previous ATAGI COVID-19 vaccine booster advice.
Protecting Older Australians – COVID-19 newsletter – 30 January 2023
In this issue: COVID-19 vaccination support; Reminder annual reporting for influenza vaccinations in aged care; and Changes to how services request Commonwealth COVID-19 Support , including RAT kits, PCR testing, Oral antiviral treatments, workforce and PPE.
Travellers from China required to undertake COVID-19 testing before travel
The Australian Government will introduce pre-departure testing for COVID-19 for people travelling to Australia from the People’s Republic of China.
ATAGI recommendations on use of the Pfizer COVID-19 vaccine for children aged 6 months to 4 years
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer COVID-19 vaccine for children aged 6 months to 4 years (Pfizer 6 months to 4 years).
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine.
ATAGI update on boosters following COVID-19 meeting on 11 November 2022
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their meeting on 11 November 2022.
New COVID-19 variant leads to increase in cases
A statement from Professor Paul Kelly, Australian Government Chief Medical Officer, on the increase in COVID-19 cases due to a new Omicron variant.
ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on Pfizer booster doses for children aged 5 to 11 years.
Protecting Older Australians – COVID-19 update 14 October 2022
In this edition: Aged care COVID-19 update webinar and COVID-19 isolation requirements for high-risk settings, including residential aged care homes.
ATAGI recommend the COVID-19 vaccination for some children aged 6 months to under 5 years
Australia’s immunisation experts, the Australian Technical Advisory Group on Immunisation, recommend COVID-19 vaccination for some children aged 6 months to under 5 years who have an increased risk of getting very sick from COVID-19. The COVID-19 vaccination will help reduce this risk.
ATAGI statement on use of the Moderna bivalent Original/Omicron vaccine
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 Moderna Spikevax Bivalent Original/Omicron BA.1 vaccine.
Date last updated: